Pharmaceutical news

Tirzepatide reduces HbA1C levels and body weight in people with type 2 diabetes

3rd March 2021

The Big Interview – Dr Jan Westerink

13th November 2020

Forxiga (dapagliflozin) gets European green light for heart failure treatment

10th November 2020

Forxiga recommended for approval in the EU for heart failure

20th October 2020

New evidence highlights limitations of premix insulins for people with type 2 diabetes

25th September 2020

People with type 1 diabetes using Toujeo® spent more time in range at night vs insulin degludec

25th September 2020

New COVID-19 and diabetes drug set for clinical trial

25th August 2020

DAPA-HF lead researcher discusses his trial findings

9th July 2020

Healthcare professionals reminded dexamethasone can impact diabetes control

18th June 2020

EU backs Canagliflozin to slow diabetic kidney disease

3rd June 2020

Insulin coach programme relaunches to plug COVID-19 hole

19th May 2020

Forxiga trial starts to see if drug can prevent COVID-19 progression

30th April 2020

A picture of the Sanofi building

Scottish green light for Suliqua and metformin combo for type 2 diabetes

17th April 2020

Diabetes management app made free to help ease NHS strain

30th March 2020

The Big Interview questions – Dr Tunde Falode

7th January 2020

A picture of the Sanofi building

Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes

5th November 2019